LNTH — Lantheus Holdings, Inc. stock price, charts and financials

QT78Lantheus Holdings, Inc.

Lantheus Holdings, Inc. (NASDAQ: LNTH) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
100.55
-0.25-0.25%
OverviewShort InterestFilings
LNTHQT78Lantheus Holdings, Inc.·NASDAQ
100.55-0.25%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 17, 2026DEFA14AAdditional proxy soliciting materials
Sep 08, 20264Statement of changes in beneficial ownership
Sep 08, 2026DEFM14ADefinitive proxy statement (merger)
Sep 04, 20264Statement of changes in beneficial ownership
Sep 04, 2026SC 13GBeneficial ownership statement (passive)
Sep 04, 2026SC 13DBeneficial ownership statement (active)
Sep 04, 2026SC 13D/ABeneficial ownership statement (active, amended)
Sep 03, 20264Statement of changes in beneficial ownership
Sep 02, 20264Statement of changes in beneficial ownership
Sep 02, 2026S-8Registration of employee benefit securities
Sep 02, 20264Statement of changes in beneficial ownership
Aug 26, 2026PREM14APREM14A
Aug 19, 20264Statement of changes in beneficial ownership
Aug 19, 20264Statement of changes in beneficial ownership
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 13, 2026DEFA14AAdditional proxy soliciting materials
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Aug 04, 2026DEFA14AAdditional proxy soliciting materials
Aug 04, 20268-KCurrent report
Aug 04, 2026DEFA14AAdditional proxy soliciting materials
Aug 03, 2026DEFA14AAdditional proxy soliciting materials
Aug 03, 20268-KCurrent report
Aug 03, 2026DEFA14AAdditional proxy soliciting materials
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
#1 / 25 of 438
Page
▼
/ 18